Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION BP

Last updated on 2017-03-28 History
Report ID 3832
Drug Identification Number 02292289
Brand name CEFTRIAXONE FOR INJECTION USP
Common or Proper name CEFTRIAXONE
Company Name SANDOZ CANADA INCORPORATED
Active Ingredient(s) CEFTRIAXONE
Strength(s) 2.0G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10 X 2G VIALS
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-03-21
Estimated end date 2017-03-31
Actual end date 2017-03-24
Shortage status Resolved
Updated date 2017-03-28
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-03-28 French Compare
v3 2017-03-28 English Compare
v2 2017-03-21 French Compare
v1 2017-03-21 English Compare